BIOLOGY
12th Edition
ISBN: 9781260169614
Author: Raven
Publisher: RENT MCG
expand_more
expand_more
format_list_bulleted
Concept explainers
Videos
Question
Chapter 26, Problem 2U
Summary Introduction
Introduction: Any group of viruses that infect and replicate within the bacteria are referred to as bacteriophages. They inject their own genetic material into the bacterial cells and use the biological machinery of the bacteria for their reproduction.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solution
Students have asked these similar questions
A study is performed in persons with an immunodeficiency disease in which activation of macrophages and B cells by CD4 cells is ineffective. It is observed that all affected persons are males. Laboratory studies show an elevated serum IgM but decreased IgG and IgA. This disorder is most likely to be caused by a mutation in a gene encoding for which of the following?
a.CD40 ligand
b.Adenine deaminase
c.Cytochrome b558
d.Complement C3
The structure of a prodrug used for treating people with HIV virus (human immunodeficiency virus) and AIDS is shown below. This molecule is a precursor of a protease inhibitor that competitively inhibits HIV protease due to its resemblance to the proteolytic site of the enzyme. Which process in the viral life cycle does this inhibitor target directly ?
Group of answer choices
a. viral protein processing for making new viruses
b. viral mRNA synthesis
c. viral DNA integration into the host cell DNA
d. viral DNA synthesis
Although slow acting retroviruses lack oncogenes, retroviral infection can activate proto oncogenes leading to oncogenesis.
a. Describe the mechanism of proto-oncogenes activation that can result from with infection with slow acting retroviruses.
b. In what other ways can proto-oncogenes be converted to oncogenes?
Chapter 26 Solutions
BIOLOGY
Ch. 26.1 - Prob. 1LOCh. 26.1 - Prob. 2LOCh. 26.2 - Prob. 1LOCh. 26.2 - Prob. 2LOCh. 26.3 - Prob. 1LOCh. 26.3 - Describe how viruses can contribute DNA to their...Ch. 26.4 - Describe the differences between acute and...Ch. 26.4 - Prob. 2LOCh. 26.4 - Prob. 3LOCh. 26.5 - Prob. 1LO
Ch. 26 - Prob. 1UCh. 26 - Prob. 2UCh. 26 - Prob. 3UCh. 26 - Prob. 4UCh. 26 - Why is a drug that blocks HIV binding to one of...Ch. 26 - Prob. 6UCh. 26 - Prob. 7UCh. 26 - Prob. 1ACh. 26 - Prob. 2ACh. 26 - Prob. 3ACh. 26 - Prob. 4ACh. 26 - Prob. 5ACh. 26 - Prob. 6ACh. 26 - Prob. 7ACh. 26 - E. coli lysogens derived from infection by phage ...Ch. 26 - Prob. 2SCh. 26 - Prob. 3SCh. 26 - Prob. 4SCh. 26 - Prob. 5S
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Similar questions
- Which of the following statements best explains why the immune system can continue to make antibodies after treatment with the anti-CD20 antibody rituximab? a. New CD20-positive B cells are reconstituted so quickly that antibody concentration during and after treatment is unaffected. b. Rituximab stimulates B-cell proliferation, so for a short while after its administration there is actually an increase in antibody concentration. c. Rituximab is a mouse monoclonal antibody and therefore its Fc region is unable to bind to the surface d. Plasma cells do not express CD20 on their cell surface, and antibody production by these cells continues unhampered. e. Rituximab stimulates anti-antibody production, leading to its rapid clearance by the body.arrow_forwardInhibiting the reverse transcriptase of HIV is a common method for treating HIV infections. a) The HIV reverse transcriptase has two separate functional domains. One domain has polymerase activity. What type of activity do you think the other domain would have?arrow_forwardModerna and Pfizer vaccines for COVID-19 use mRNA to the Spike protein combined with lipids. Which of the following is/are advantages of this type of vaccine compared to an inactivated virus vaccine? Select ALL correct answers. a) The vaccine is more stable for transport. b) The vaccine does not contain the virus so it cannot give you COVID-19. c) The vaccine can be rapidly produced in a slightly different form to protect from variants of SARS-CoV-2. d) The vaccine does not need a booster.arrow_forward
- You have a leu auxotroph strain of e. coli. You suspect that if you mutagenize this strain, you can isolate prototrophic revertants. You irradiate these cells to generate mutants. A) What media should you plate these mutants on to identify leu prototrophs? answers: a. minimal media + carbon source b. minimal media - leu c. rich media d. rich media + ampicillin e. rich media -trparrow_forwardEpstein-Barr virus is associated with Burkitt’s lymphoma. The rate of EBV and c-myc gene translocation seems related, as both are highest in Equatorial Africa, lowest in North America and intermediate in South America. Explain what is c-myc translocation and why it results in overexpression of c-myc. What is the role of EBV in causing c-myc gene overexpression?arrow_forwardSeveral vaccines against viral infections are made by isolating purified surface proteins of the viral particle, mixing them with an adjuvant to stimulate an innate immune response, and injecting the mixture into people. Two examples of this are the vaccine against Hepatitis B virus, and the vaccine against Human Papilloma Virus (the ‘cervical cancer’ vaccine). One interesting property of vaccines of this type (known as ‘subunit vaccines’) is that there is a requirement for a CD4 T cell response to the vaccine antigen in order to generate antibodies to the innocuous protein in the vaccine. In the case of the Hepatitis B vaccine, the viral protein included in the vaccine is the Hepatitis B surface antigen (HepB-SAg), a protein that is approximately 200 amino acids in length. The graph in Figure Q4.27 shows the data from immunizing individuals with this vaccine, and monitoring their production of protective antibody responses to the viral protein. a) What results would be predicted if…arrow_forward
- When Griffith incubated heat-killed virulent S strain bacteria with live avirulent R strains, he found that R cells were transformed into lethal, disease-causing bacteria. What is the molecule responsible for the transformation of R cells into the S type? Why did the transformation occur? A. Proteins in the heat-killed S cell extract; they were able to synthesize the capsular polysaccharide in the R cells and make them virulent. B. The capsular polysaccharide in the heat-killed S cell extract; the polysaccharide was able to attach to R cells, thus making them virulent. C. DNA in the heat-killed S cell extract; the DNA altered the genetic makeup of R cells, allowing them to synthesize the polysaccharide capsule, thus making them virulent. D. Specialized lipids in the cell membrane of the S cells were able to integrate with the R cells, conferring the ability to evade host immunity.arrow_forwardYou work for a large biotechnology company that is studying viruses, vaccines, and small molecule inhibitors. You are asked to give an overview of cell signaling as it relates to the coronavirus and young adults. a) Describe cell signaling pathways (e.g., at least 3) that are likely manipulated during a coronavirus infection. In your description, include how the pathways are involved in antagonizing the host antiviral response.arrow_forwardA gene contains the sequence CGCATACGGTAC that results in the amino acid sequence arg-ile-arq- tyr. A mutation in this gene has a G inserted after the second C in the strand. How will this mutation affect the phenotype? A)This will affect the phenotype because although most of the protein will be identical, the first amino acid will be different. B)This will not affect the phenotype because only the second amino acid is different from the original protein. C)This will not affect the phenotype because the protein will be identical to the original protein. D)This will affect the phenotype because all of the amino acids after the first one will be different from the original protein.arrow_forward
- Based on these data, where would you MOST likely find toll-like receptor-XX (TLR-XX) among the following options? Justify WHY you selected that option.Your justification must be based on the data that are presented here, not the type of bacteria. A. On the cell surface B. In the endosome/ lysosome C. In the nucleus D. In the mitochondria E. In the endoplasmic reticulumarrow_forwardYou’re researching the effect of two drugs (Drug A and Drug B) on colon carcinoma cells in vitro. You begin by performing an assay to determine the effect of the drugs on cell viability and generate the data below in the graph below (A). With the aim of determining the mechanism of action of the drugs, you subsequently investigate levels of several key apoptotic proteins via SDS-PAGE and Western blot (B). To measure cytochrome C, you first separate the mitochondrial fragments from the cytosolic fragments and measure the levels of cytochrome C in each. You measure the remaining proteins using whole-cell lysates. B-Actin was included as a loading control. This data is represented on the right below. Part 1 Which drug is most likely inducing apoptosis? Explain your reasoning with referent to the cellular events that have taken place in response to the drugs, based on the data Part 2 Is it possible to determine from this data I the activation of apoptosis is occurring through the intrinsic…arrow_forwardA virus is a submicroscopic infectious agent that replicates only inside the living cells of an organism. It does this by inserting its genetic material (RNA) into the host cell and integrate its genetic material with the host genome. Explain in details how organisms eliminate the expression of viral genes? How this mechanism can prevent virus infections?arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSON
Biology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStax
Anatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & Company
Laboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:PEARSON
Biology 2e
Biology
ISBN:9781947172517
Author:Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:OpenStax
Anatomy & Physiology
Biology
ISBN:9781259398629
Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:9780815344322
Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:9781260159363
Author:Martin, Terry R., Prentice-craver, Cynthia
Publisher:McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Biology
ISBN:9781260231700
Author:Sylvia S. Mader, Michael Windelspecht
Publisher:McGraw Hill Education
Mitochondrial mutations; Author: Useful Genetics;https://www.youtube.com/watch?v=GvgXe-3RJeU;License: CC-BY